These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25047306)

  • 21. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.
    Lavretsky H; Reinlieb M; St Cyr N; Siddarth P; Ercoli LM; Senturk D
    Am J Psychiatry; 2015 Jun; 172(6):561-9. PubMed ID: 25677354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the late-life function and disability instrument to assess disability in major depression.
    Karp JF; Skidmore E; Lotz M; Lenze E; Dew MA; Reynolds CF
    J Am Geriatr Soc; 2009 Sep; 57(9):1612-9. PubMed ID: 19682111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are Apathy and Depressive Symptoms Related to Vascular White Matter Hyperintensities in Severe Late Life Depression?
    Oudega ML; Siddiqui A; Wattjes MP; Barkhof F; Kate MT; Muller M; Bouckaert F; Vandenbulcke M; De Winter FL; Sienaert P; Stek ML; Comijs HC; Korten NCM; Emsell L; Eikelenboom P; Rhebergen D; van Exel E; Dols A
    J Geriatr Psychiatry Neurol; 2021 Jan; 34(1):21-28. PubMed ID: 32036772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social support deficit and depression treatment outcomes in patients with acute coronary syndrome: Findings from the EsDEPACS study.
    Kim JW; Kang HJ; Bae KY; Kim SW; Shin IS; Yoon JS; Hong YJ; Ahn Y; Jeong MH; Kim JM
    Int J Psychiatry Med; 2019 Jan; 54(1):39-52. PubMed ID: 30079814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
    Kilts CD; Wade AG; Andersen HF; Schlaepfer TE
    Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression.
    Lenze EJ; Munin MC; Skidmore ER; Dew MA; Rogers JC; Whyte EM; Quear T; Begley A; Reynolds CF
    J Am Geriatr Soc; 2007 Jan; 55(1):81-6. PubMed ID: 17233689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram.
    Rampello L; Alvano A; Raffaele R; Malaguarnera M; Vecchio I
    J Clin Psychopharmacol; 2006 Feb; 26(1):67-70. PubMed ID: 16415709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
    Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
    J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escitalopram versus placebo in the treatment of dysthymic disorder.
    Hellerstein DJ; Batchelder ST; Hyler S; Arnaout B; Toba C; Benga I; Gangure D
    Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is apathy in late-life depressive illness related to age-at-onset, cognitive function or vascular risk?
    Lampe IK; Heeren TJ
    Int Psychogeriatr; 2004 Dec; 16(4):481-6. PubMed ID: 15715362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES; Howard C; Khan DA; Carmody TJ
    Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].
    Schmitt L; Arbus C; Tonnoir B
    Encephale; 2006; 32(2 Pt 1):270-7. PubMed ID: 16910629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
    Brunoni AR; Moffa AH; Sampaio-Junior B; Borrione L; Moreno ML; Fernandes RA; Veronezi BP; Nogueira BS; Aparicio LVM; Razza LB; Chamorro R; Tort LC; Fraguas R; Lotufo PA; Gattaz WF; Fregni F; Benseñor IM;
    N Engl J Med; 2017 Jun; 376(26):2523-2533. PubMed ID: 28657871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP; Huusom AK; Florea I; Baekdal T; Sarchiapone M
    Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of demotivation and affective disorders in apathy in patients with Parkinson's disease without dementia and depression].
    Delgadillo-Iniguez D; Derouesné C; Lacomblez L; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):197-207. PubMed ID: 23803637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
    Li H; Li T; Li G; Luo J
    Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive, Disability, and Treatment Outcome Implications of Symptom-Based Phenotyping in Late-Life Depression.
    Sudol K; Conway C; Szymkowicz SM; Elson D; Kang H; Taylor WD
    Am J Geriatr Psychiatry; 2023 Nov; 31(11):919-931. PubMed ID: 37385899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.
    Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I
    Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.
    Schmitt L; Tonnoir B; Arbus C
    Neuropsychobiology; 2006; 54(4):201-7. PubMed ID: 17337913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.